About BBRB

BBRB is an international leader in research and policy activities related to biospecimen collection, processing, and storage, also known as biobanking. Biospecimens, such as tumor tissues and blood, are essential for the study of disease and have been a key component of scientific breakthroughs that have led to a better understanding of how to better diagnose and treat cancer. BBRB drives medical discovery and precision medicine by providing leadership, tools and resources to the biobanking community as well as by guiding policy related to biobanking in order to promote the availability of biospecimens for research.

BBRB’s efforts include the development and implementation of evidence-based standardized procedures for biospecimen science and research; biospecimen science research on the effects of biospecimen preanalytical factors; the support and coordination of major scientific initiatives requiring high-quality biospecimens such as the Cancer Moonshot Biobank and the Genotype-Tissue Expression (GTEx) project; and investigations into the ethical, legal, and social issues (ELSI) (https://biospecimens.cancer.gov/programs/ethics/) concerning biospecimen collection and use. These are just a few examples of how BBRB works to improve the usefulness and reproducibility of scientific research to expedite better and more effective treatments into the clinic.